Other
German biotech company MorphoSys buys US rival for $1.7B
Germany-based MorphoSys AG said Wednesday that it is buying U.S. rival Constellation Pharmaceuticals Inc. in a deal valuing the biotech company at $1.7 billion.
Jun 2, 2021
0
0
News tagged with biotech company
Vaccination
Moderna, the small biotech company taking on the pandemic
Moderna has long been a darling of investors but it wasn't until the coronavirus pandemic came along that the Cambridge, Massachusetts-based biotech company could prove the value of its new vaccine technology and mint some ...
Nov 17, 2020
0
1
Vaccination
Moderna already has $1.1 bn in deposits for Covid-19 vaccine
Moderna said Thursday it took in $1.1 billion in deposits in the third quarter for a coronavirus vaccine that it is "actively preparing" to launch.
Oct 29, 2020
0
1
Diseases, Conditions, Syndromes
Mexico warns setback in tests could delay vaccine
The Latin American roll-out of a potential COVID-19 vaccine made by AstraZeneca could be set back after the biotech company announced a pause in tests, the government of Mexico, which is involved in developing the drug alongside ...
Sep 9, 2020
0
2
Diseases, Conditions, Syndromes
Gilead says drug helped moderately ill coronavirus patients
A California biotech company says its experimental drug remdesivir improved symptoms when given for five days to moderately ill, hospitalized patients with COVID-19.
Jun 1, 2020
0
2
Diseases, Conditions, Syndromes
Gilead drug proves effective against coronavirus in US study (Update)
For the first time, a major study suggests that an experimental drug works against the new coronavirus, and U.S. government officials said Wednesday that they would work to make it available to appropriate patients as quickly ...
Apr 29, 2020
1
30
Cardiology
Researchers trace the molecular roots of potentially fatal heart condition
The heart's ability to beat normally over a lifetime is predicated on the synchronized work of proteins embedded in the cells of the heart muscle.
Jan 27, 2020
0
78
Diseases, Conditions, Syndromes
This Ebola drug is heading to the Congo. Can it be tested during civil war?
As the fast-moving Ebola virus sweeps through eastern Congo, scientists are braving war zones hoping to test new medicines on sick patients there.
Feb 27, 2019
0
0
Medications
Jury orders Gilead to pay Merck $2.5bn in patent case
A US jury has ordered pharmaceutical giant Gilead Sciences to pay $2.5 billion to competitor Merck in a patent infringement case involving a drug used to treat hepatitis C, the two companies said.
Dec 16, 2016
0
0
Oncology & Cancer
New technology isolates pure tumor cells from FFPE samples
Using the innovative DEPArray technology, scientists at Silicon Biosystems, a Bologna (Italy) and San Diego (CA, USA) based biotech company, were able to solve one of the biggest limitation in the study of cancer genetic: ...
Feb 19, 2016
0
7
